Skip to content

Clinical trials

Phase 2 Diabetes Mellitus trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 2 Country / region: Australia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20072
20081
20101
20121
20133
20151
20221
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting2
Terminated2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S2
University of Sydney2
DiObex1
Kailera1
Myopharm Limited1
NGM Biopharmaceuticals, Inc1
Osprey Medical, Inc1
Pharming Technologies B.V.1
Resverlogix Corp1
Royal Adelaide Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus16
Diabetes Mellitus, Type 24
Diabetes Mellitus, Type 12
Diabetic Retinopathy2
Autoimmune Diseases1
Diabetic Neuropathies1
Endocrine System Diseases1
Gastroparesis1
Glucose Metabolism Disorders1
Infections1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.